
![]()
![]()
![]()
![]()
You are viewing the World Edition
Choose the news you want to read
View the site in World Edition, U.S. News Edition
European News Edition or Asia Pacific News Edition

TMO Renewables Limited is a leader in the development of second generation sustainable biofuels. TMO’s process is capable of utilising all of the sugars, including complex longer chain forms, derived from biomass and their high temperature process is capable of producing fuel ethanol at high efficiency and high conversion rates. TMO intends to build the UK’s first cellulosic ethanol Process Demonstation Unit during 2007 which will integrate all the necessary steps in a continuous ethanol production process. TMO’s integrated sustainable approach to ethanol production utilises readily available and low cost biomass feedstocks. Furthermore, the process can be a net energy contributor by applying energy recovery techniques.
| Hamish Curran, Chief Executive Officer |
| Hamish joined TMO in 2006 with over 20 years of international management and consulting experience in the energy and renewables sector. Hamish joined from Argent Energy, where he was Chief Operating Officer and was responsible for the construction, start-up and commissioning of the first industrial scale bio-diesel plant in the UK. Prior positions have included Managing Director for WaveGen, General Manager within British-Borneo Oil & Gas plc, General Manager and Asset Director for JKX &Gas plc. |
| A former member of the UK Government Oil & Gas Industry Task force, Hamish has broad experience of cross border projects as well as a consulting record demonstrating the ability to identify and deliver measurable improvement at board level and at “shop floor”. Hamish has delivered results ranging from major corporate M&A activity to focussed strategic asset advice and analysis. |
| Christopher Miller, Chairman / non-executive Director |
| Age 54, he qualified as a chartered accountant with Coopers & Lybrand, following which he was an Associate Director of Hanson plc. In September 1988 he joined the Board of Wassall PLC as its Chief Executive. Between October 2000 and May 2003 he was involved in private investment activities. Mr Miller was appointed as an executive Director of Melrose on 29 May 2003. He is currently Chairman of Melrose plc. |
| Dr. Anthony Atkinson B.Sc., Ph.D, FIIB, FIoN, Research & Development Director |
| After 25 years with the UK Centre for Applied Microbiology and Research (CAMR) where he was Deputy Director and Director of the Commercial Biotechnology Division, Tony moved on in 1994 to pursue his industrial and commercial interests. Tony has consulted for Schering-Plough, DuPont and ICI and was on UK regulatory and advisory committees in biosciences and nanotechnology. A former member of the Advisory Board of Merlin Ventures, Tony has interests in several other biotech companies. Tony was CEO of Enact Pharma PLC, which acquired Enzacta PLC and was later sold to Protherics PLC. He is currently Non-Executive director of Biofusion Plc and Chairman of Morvus Technology Limited. Tony has published over 400 scientific papers and registered 20 patents, many of which are licensed to the likes of Boehringer, Biogen and DuPont. Over 120 of these papers relate to the biotechnology of thermophiles and their products. TMO benefits from Tony’s unique experience in thermophile genetics and manipulation. Tony is also responsible for TMO’s patent and IP strategy and all laboratory research. |
Company Address40 Alan Turing Road, Surrey Research Park
|